Berlin - Delayed Quote EUR

Akero Therapeutics Inc (0K4.BE)

Compare
53.72
-0.02
(-0.04%)
As of 1:55:13 PM GMT+1. Market Open.
Currency in EUR All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Expense
269,271.00
172,870.00
115,156.00
100,886.00
80,154.00
Operating Income
-269,271.00
-172,870.00
-115,156.00
-100,886.00
-80,154.00
Net Non Operating Interest Income Expense
32,049.00
21,111.00
3,123.00
109.00
--
Other Income Expense
--
--
3,862.00
109.00
947.00
Pretax Income
-237,222.00
-151,759.00
-112,033.00
-100,777.00
-79,207.00
Net Income Common Stockholders
-237,222.00
-151,759.00
-112,033.00
-100,777.00
-79,207.00
Diluted NI Available to Com Stockholders
-237,222.00
-151,759.00
-112,033.00
-100,777.00
-79,207.00
Basic EPS
-3.78
-2.89
-2.87
-2.89
-2.52
Diluted EPS
-3.78
-2.89
-2.87
-2.89
-2.52
Basic Average Shares
63,425.18
52,568.16
38,984.77
34,827.39
31,463.25
Diluted Average Shares
63,425.18
52,568.16
38,984.77
34,827.39
31,463.25
Total Operating Income as Reported
-269,271.00
-172,870.00
-115,156.00
-100,886.00
-80,154.00
Total Expenses
269,271.00
172,870.00
115,156.00
100,886.00
80,154.00
Net Income from Continuing & Discontinued Operation
-237,222.00
-151,759.00
-112,033.00
-100,777.00
-79,207.00
Normalized Income
-237,222.00
-151,759.00
-112,033.00
-100,777.00
-79,207.00
Interest Income
36,414.00
24,210.00
3,862.00
109.00
--
Interest Expense
4,365.00
3,099.00
739.00
--
--
Net Interest Income
32,049.00
21,111.00
3,123.00
109.00
--
EBIT
-232,857.00
-148,660.00
-111,294.00
-100,777.00
-80,154.00
EBITDA
-232,852.00
-148,631.00
-111,251.00
-100,736.00
-80,137.00
Reconciled Depreciation
5.00
29.00
43.00
41.00
17.00
Net Income from Continuing Operation Net Minority Interest
-237,222.00
-151,759.00
-112,033.00
-100,777.00
-79,207.00
Normalized EBITDA
-232,852.00
-148,631.00
-111,251.00
-100,736.00
-80,137.00
12/31/2020 - 7/5/2019

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

1U5.F Wave Life Sciences Ltd.
11.40
+2.70%
 
9IP1.F Rocket Pharmaceuticals, Inc.
9.94
+3.37%
 
GNRO.PA GeNeuro SA
0.1500
-8.26%
 
37Z.DU Allakos Inc
0.2329
+0.13%
 
SXTPW 60 Degrees Pharmaceuticals, Inc.
0.0327
-17.84%
 
COYA Coya Therapeutics, Inc.
5.86
+0.17%
 
22UA.DE BioNTech SE
117.40
-1.01%
 
HCWB HCW Biologics Inc.
0.2748
+6.06%
 
EDSA Edesa Biotech, Inc.
1.8900
+1.07%
 
ANIX Anixa Biosciences, Inc.
2.9400
-2.00%